Network pharmacology based investigation into the effect and mechanism of Modified Sijunzi Decoction against the subtypes of chronic atrophic gastritis
- 1 June 2019
- journal article
- research article
- Published by Elsevier in Pharmacological Research
- Vol. 144, 158-166
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation (81522051)
- National Key R&D Program of China (2017YFC1700106)
This publication has 22 references indexed in Scilit:
- Chronic gastritis in China: a national multi-center surveyBMC Gastroenterology, 2014
- Autoimmune atrophic gastritis—pathogenesis, pathology and managementNature Reviews Gastroenterology & Hepatology, 2013
- Imbalanced network biomarkers for traditional Chinese medicine Syndrome in gastritis patientsScientific Reports, 2013
- Recent Highlights of Metabolomics in Chinese Medicine Syndrome ResearchEvidence-Based Complementary and Alternative Medicine, 2013
- Prevalence of Chronic Atrophic Gastritis in Different Parts of the WorldCancer Epidemiology, Biomarkers & Prevention, 2006
- Atrophic Gastritis Is Associated with Increased Sucrose Permeability Related to Chronic InflammationDigestion, 2005
- CD4+CD45RBHi Interleukin-4 Defective T Cells Elicit Antral Gastritis and DuodenitisThe American Journal of Pathology, 2004
- Interleukin 1β polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in JapanGastroenterology, 2002
- Echinacea purpurea and Melatonin Augment Natural-Killer Cells in Leukemic Mice and Prolong Life SpanThe Journal of Alternative and Complementary Medicine, 2001
- Prevalence of Undiagnosed Pernicious Anemia in the ElderlyArchives of internal medicine (1960), 1996